Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

References

• Thomas E, Fitzpatrick J, Etl Al MS, Taylor-Robinson SD, Bell JD. Whole body fat: content and distribution. Prog Nucl Magnet Res Spect. 2013;73:56–80. doi:10.1016/j.pnmrs.2013.04.001
   PubMed Web of Science ®Google Scholar
• Kuryszko J, Sławuta P, Sapikowski G. Secretory function of adipose tissue. Pol J Veterin Sci. 2016;19:441–446. doi:10.1515/pjvs-2016-0056
   PubMed Web of Science ®Google Scholar
• Colaianni G, Colucci S, Grano M. Anatomy and physiology of adipose tissue. In: Lenzi A, Migliaccio S, Donini L, editors. Multidisciplinary Approach to Obesity. Springer International Publishing; 2015:3–12.
   Google Scholar
• Buczkowska M, Buczkowski K, Głogowska-Gruszka A, et al. Adipose tissue – the structure and its functions, with particular emphasis on the characteristics of selected adipokines and their effects on the organism. Med Og Nauk Zdr. 2019;25:162–169. doi:10.26444/monz/110429
   Google Scholar
• Budzulak J, Majewska KA, Kędzia A. Malnutrition as the cause of growth retardation among children in developed countries. Ann Agric Environ Med. 2022;29:336–341. doi:10.26444/aaem/148010
   Web of Science ®Google Scholar
• Drygas W, Niklas AA, Piwońska A, et al. Multi-centre national population health examination survey (WOBASZ II study): assumptions, methods, and implementation. Kardiologia Polska (Polish Heart Journal). 2016;74:681–690. doi:10.5603/KP.a2015.0235
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO EUROPEAN REGIONAL OBESITY REPORT 2022. Denmark; 2022.
   Google Scholar
• Płaczkowska S, Pawlik-Sobiecka L, Kokot I, et al. Wykorzystanie bezpośrednich i pośrednich metod oceny profilu składu ciała u młodych osób – badanie pilotażowe. Fam Med Prim Care Rev. 2015;1:33–38.
   Google Scholar
• Tchang BG, Saunders KH, Igel LI. Best practices in the management of overweight and obesity. Med Clin North Am. 2021;105:149–174. doi:10.1016/j.mcna.2020.08.018
   PubMed Web of Science ®Google Scholar
• Łuniewski M, Matyjaszek-Matuszek B, Lenart-Lipińska M. Diagnosis and non-invasive treatment of obesity in adults with type 2 diabetes mellitus: a review of guidelines. J Clin Med. 2023;12:4431. doi:10.3390/jcm12134431
   PubMedGoogle Scholar
• Gaesser GA, Angadi SS. Obesity treatment: weight loss versus increasing fitness and physical activity for reducing health risks. iScience. 2021;24:102995. doi:10.1016/j.isci.2021.102995
   PubMed Web of Science ®Google Scholar
• Bogdański P, Filipiak KJ, Kowalska I, et al. Interdyscyplinarne stanowisko w sprawie rozpoznawania i leczenia otyłości. Forum Zaburzen Metabolicznych. 2020;11:47–54.
   Google Scholar
• Ellulu MS, Patimah I, Khaza’ai H, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;4:851–863. doi:10.5114/aoms.2016.58928
   Web of Science ®Google Scholar
• Khanna D, Khanna S, Khanna P, et al. Obesity: a Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022;14(2):e22711. doi:10.7759/cureus.22711
   PubMed Web of Science ®Google Scholar
• Kolb H. Obese visceral fat tissue inflammation: from protective to detrimental? BMC Med. 2022;20:494. doi:10.1186/s12916-022-02672-y
   PubMed Web of Science ®Google Scholar
• Chwalba A, Machura E, Ziora K, Ziora D. The role of adipokines in the pathogenesis and course of selected respiratory diseases. Endokrynol Pol. 2019;70:504–510. doi:10.5603/EP.a2019.0051
   PubMed Web of Science ®Google Scholar
• Cook KS, Min HY, Johnson D, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 1987;237(4813):402–405. doi:10.1126/science.3299705
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;1(372):6505.
   Google Scholar
• Al-Hussaniy HA, Alburghaif AH, Naji MA. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J Med Life. 2021;14(5):600–605. doi:10.25122/jml-2021-0153
   PubMedGoogle Scholar
• Abdalla MMI. Role of visfatin in obesity-induced insulin resistance. World J Clin Cases. 2022;10:10840–10851. doi:10.12998/wjcc.v10.i30.10840
   PubMed Web of Science ®Google Scholar
• Borsuk A, Biernat W, Zięba D, et al. Wielokierunkowe działanie rezystyny w organizmie. Postępy Higieny i Medycyny Doświadczalnej. 2018;72:327–338. doi:10.5604/01.3001.0011.8252
   Google Scholar
• Gandham R, Sumathi M, Dayanand C, et al. Apelin and its Receptor: an Overview. JCDR. 2019;13(6):BE01- BE06.
   Web of Science ®Google Scholar
• Stojek M. The role of chemerin in human disease. Postepy Hig Med Dosw. 2017;71:110–117. doi:10.5604/01.3001.0010.3795
   Web of Science ®Google Scholar
• Roguska J, Zubkiewicz-Kucharska A. Chemerin as an early marker of metabolic syndrome. Pediatr Endocrinol Diabetes Me. 2018;24:45–51. doi:10.18544/PEDM-24.01.0102
   PubMedGoogle Scholar
• Badowska-Kozakiewicz AM. Biologiczna rola czynnika martwicy nowotworów α w fizjologii i patofizjologii. Przeglad Menopauzalny. 2013;141:12.
   Google Scholar
• Dobrowolski P, Dudek D, Dyrbuś K,et al.; A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Metabolic syndrome – a new definition and management guidelines. Arch Med Sci. 2022;18:1133–1156.
   PubMed Web of Science ®Google Scholar
• Wyrzykowski B. Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. Kardiologia Polska. 2005;63(6).
   Google Scholar
• Mohamed SM, Shalaby MA, El-Shiekh RA, et al. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem Advan. 2023;3:100335. doi:10.1016/j.focha.2023.100335
   Google Scholar
• Wang Y, Chen D, Zhang Y, et al. Novel adipokine, FAM19A5, inhibits neointima formation after injury through sphingosine-1-phosphate receptor 2. Circulation. 2018;138:48–63. doi:10.1161/CIRCULATIONAHA.117.032398
   PubMed Web of Science ®Google Scholar
• Shahapal A, Cho EB, Yong HJ, et al. FAM19A5 expression during embryogenesis and in the adult traumatic brain of FAM19A5-lacz knock-in mice. Front Neurosci. 2019;13:917. doi:10.3389/fnins.2019.00917
   PubMed Web of Science ®Google Scholar
• Park M, Kim HS, Lee M, et al. FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2. Sci Rep. 2017;7. doi:10.1038/s41598-017-15586-0
   Web of Science ®Google Scholar
• Xie K, Liu L, Yin C, et al. Follistatin-Like 1 and family with sequence similarity to 19 member a5 levels are decreased in obese children and associated with glucose metabolism. Ann Nutr Metab. 2022;78:213–221. doi:10.1159/000524624
   PubMed Web of Science ®Google Scholar
• Tom Tang Y, Emtage P, Funk WD, et al. TAFA: a novel secreted family with conserved cysteine residues and restricted expression in the brain. Genomics. 2004;83:727–734. doi:10.1016/j.ygeno.2003.10.006
   PubMed Web of Science ®Google Scholar
• de Ståhl T D, Hartmann C, de Bustos C, et al. Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme. Gen Chromos Can. 2005;44:161–169. doi:10.1002/gcc.20226
   PubMed Web of Science ®Google Scholar
• Kashevarova AA, Belyaeva EO, Nikonov AM, et al. Compound phenotype in a girl with r(22), concomitant microdeletion 22q13.32-q13.33 and mosaic monosomy 22. Mol Cytogenet. 2018;11:26. doi:10.1186/s13039-018-0375-3
   PubMed Web of Science ®Google Scholar
• Zheng C, Chen D, Zhang Y,et al.FAM19A1 is a new ligand for GPR1 that modulates neural stem-cell proliferation and differentiation. FASEB J. 2018;fj201800020RRR. doi:10.1096/fj.201800020RRR
   Google Scholar
• Inan C, Sayin NC, Gurkan H, et al. Schizencephaly accompanied by occipital encephalocele and deletion of chromosome 22q13.32: a case report. Fetal Pediatr Pathol. 2019;38:496–502. doi:10.1080/15513815.2019.1604921
   PubMed Web of Science ®Google Scholar
• Khalaj AJ, Sterky FH, Sclip A, et al. Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism. J Cell Biol. 2020;219:e202004164. doi:10.1083/jcb.202004164
   PubMed Web of Science ®Google Scholar
• Yong HJ, Ha N, Cho EB, et al. The unique expression profile of FAM19A1 in the mouse brain and its association with hyperactivity, long-term memory and fear acquisition. Sci Rep. 2020;10:3969. doi:10.1038/s41598-020-60266-1
   PubMed Web of Science ®Google Scholar
• Li J, Li S, Song Y, et al. Association of serum FAM19A5 with cognitive impairment in vascular dementia. Dis Markers. 2020;2020:8895900. doi:10.1155/2020/8895900
   PubMed Web of Science ®Google Scholar
• Lee HL, Seok HY, Ryu H-W, et al. Serum FAM19A5 in neuromyelitis optica spectrum disorders: can it be a new biomarker representing clinical status? Mult Scler. 2020;26:1700–1707. doi:10.1177/1352458519885489
   PubMed Web of Science ®Google Scholar
• Huang S, Zheng C, Xie G, et al. FAM19A5/TAFA5, a novel neurokine, plays a crucial role in depressive-like and spatial memory-related behaviors in mice. Mol Psychiatry. 2021;26:2363–2379. doi:10.1038/s41380-020-0720-x
   PubMed Web of Science ®Google Scholar
• Han KM, Tae W-S, Kim A, et al. Serum FAM19A5 levels: a novel biomarker for neuroinflammation and neurodegeneration in major depressive disorder. Brain Behav Immun. 2020;87:852–859. doi:10.1016/j.bbi.2020.03.021
   PubMed Web of Science ®Google Scholar
• Abdallah MS, Ramadan AN, Omara‐Reda H, et al. Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder. CNS Neurosci Ther. 2021;27:1540–1548. doi:10.1111/cns.13731
   PubMed Web of Science ®Google Scholar
• Li XN, Hao D-P, Qu M-J, et al. Development and validation of a plasma FAM19A5 and MRI-based radiomics model for prediction of parkinson’s disease and parkinson’s disease with depression. Front Neurosci. 2021;15:795539. doi:10.3389/fnins.2021.795539
   PubMed Web of Science ®Google Scholar
• Janvilisri T, Leelawat K, Roytrakul S, et al. Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. Dis Markers. 2015;2015:105358. doi:10.1155/2015/105358
   PubMed Web of Science ®Google Scholar
• Hu Z, Niu G, Ren J, et al. TAFA5 promotes proliferation and migration in gastric cancer. Mol Med Rep. 2019;20:4477–4488. doi:10.3892/mmr.2019.10724
   PubMed Web of Science ®Google Scholar
• Wang YF, Huang S-Y, Zhang Z-H, et al. Clinical efficacy of allo-HSCT on FLT3-ITD positive AML patients. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020;28(4):1183–1188. doi:10.19746/j.cnki.issn.1009-2137.2020.04.017
   PubMedGoogle Scholar
• Luan S, Li J, Qin S, et al. FAM19A5 is an independent prognostic biomarker in thyroid cancer. Res Square. 2022. doi:10.21203/rs.3.rs-1712708/v1
   Google Scholar
• Pan X, Karner CM, Carroll TJ. Myc cooperates with β-catenin to drive gene expression in nephron progenitor cells. Development. 2017;144:4173–4182. doi:10.1242/dev.153700
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Z, Wan W, et al. FAM19A5/S1PR1 signaling pathway regulates the viability and proliferation of mantle cell lymphoma. J Recept Signal Transduction Res. 2022;42:225–229. doi:10.1080/10799893.2021.1895220
   PubMed Web of Science ®Google Scholar
• Sevane N, Martínez R, Bruford MW. Genome-wide differential DNA methylation in tropically adapted Creole cattle and their Iberian ancestors. Anim Genet. 2019;50:15–26. doi:10.1111/age.12731
   PubMed Web of Science ®Google Scholar
• Hao Z, Yang S, Yin R, et al. Increased level of FAM19A5 is associated with cerebral small vessel disease and leads to a better outcome. PeerJ. 2022;10:e13101. doi:10.7717/peerj.13101
   PubMed Web of Science ®Google Scholar
• Paulsen SJ, Christensen MT, Vrang N, et al. The putative neuropeptide TAFA5 is expressed in the hypothalamic paraventricular nucleus and is regulated by dehydration. Brain Research. 2008;1199:1–9. doi:10.1016/j.brainres.2007.12.074
   PubMed Web of Science ®Google Scholar
• Lee YB, Hwang H-J, Kim JA, et al. Association of serum FAM19A5 with metabolic and vascular risk factors in human subjects with or without type 2 diabetes. Diab Vasc Dis Res. 2019;16:530–538. doi:10.1177/1479164119860746
   PubMed Web of Science ®Google Scholar
• Lei X, Liu L, Terrillion CE, et al. FAM19A1, a brain-enriched and metabolically responsive neurokine, regulates food intake patterns and mouse behaviors. THE FASEB Journal. 2019;33:14734–14747. doi:10.1096/fj.201901232RR
   PubMed Web of Science ®Google Scholar
• Yari FA, Shabani P, Karami S, et al. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease. BMC Endocr Disord. 2021;21:153. doi:10.1186/s12902-021-00820-8
   PubMed Web of Science ®Google Scholar
• Wesolek A, Skoracka K, Skrypnik K, et al. Assessment of progranulin and FAM19A5 protein blood levels in patients with metabolic syndrome. J Physiol Pharmacol. 2022;73.
   Web of Science ®Google Scholar
• Kwak H, Cho EH, Lee YN, et al. Is FAM19A5 an adipokine? Peripheral FAM19A5 in wild-type, FAM19A5 knock-out, and LacZ knock-in mice. bioRxiv. 2020. doi:10.1101/2020.02.19.955351
   Google Scholar
• Bundzikova J, Pirnik Z, Zelena D, et al. Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and brattleboro rats. Cell Mol Neurobiol. 2008;28:1033–1047. doi:10.1007/s10571-008-9306-x
   PubMed Web of Science ®Google Scholar
• Kang D, Kim HR, Kim KK, et al. Brain-specific chemokine FAM19A5 induces hypothalamic inflammation. Biochem Biophys Res Commun. 2020;523:829–834. doi:10.1016/j.bbrc.2019.12.119
   PubMed Web of Science ®Google Scholar
• An B, Xia J, Chang T, et al. Genome-wide association study reveals candidate genes associated with body measurement traits in Chinese wagyu beef cattle. Anim Genet. 2019;50:386–390. doi:10.1111/age.12805
   PubMed Web of Science ®Google Scholar
• Ma F, Hao J, Zhao J, et al. Circulating FAM19A5 level is associated with the presence and severity of coronary artery disease. Int J Cardiol. 2022;354:50–55. doi:10.1016/j.ijcard.2022.03.011
   PubMed Web of Science ®Google Scholar
• Wei C, Liu Y, Xing E, et al. Association between novel pro- and anti- inflammatory adipocytokines in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2022;28:10760296221128020. doi:10.1177/10760296221128021
   Web of Science ®Google Scholar